UNSPSC 51111751: Ortetamine

This classification denotes an anorexiant with the molecular formula C10H15N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VF4N11KKKR, chemically known as 1,1-dimethyl-2-phenylethylamine but generally known as ortetamine, which bears US NIH Compound Identifier 4771. European Medicines Agency schedules Ortetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09472MIG. The term ORTETAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5).

UNSPSC 51111751 Ortetamine is a Commodity code that state and local governments are using to procure pharmaceutical products and medical supplies, though recent opportunities tagged under this code show a broader pattern of naloxone, first aid supplies, and generic pharmaceutical sourcing rather than ortetamine specifically. State and local issuing bodies soliciting under or near this code span county health departments, municipal fire departments, state health and human services agencies, and cooperative purchasing alliances. Seminole County, Florida and the City of Tampa's Fire Department have posted recent bids for naloxone, safe drug deactivation systems, and emergency medical supplies (IFB 60459723LAS and ITB 26P00145), while the Texas Health and Human Services Commission issued a Request for Information on direct-to-manufacturer prescription programs, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administering on behalf of Minnesota Department of Administration and participating states including Oregon released an RFP for generic multi-source pharmaceuticals and OTC products. The work reflects a mix of emergency response supply procurement, pharmaceutical product sourcing through wholesaler networks, and healthcare system-wide acquisition of consumable medical items.

Recent activity shows geographic spread across Florida, Texas, Minnesota, and Oregon, with cooperative purchasing mechanisms emerging as a significant channel for multistate pharmaceutical procurement. Seminole County's naloxone and drug deactivation systems bid closes July 26, 2026 with quarterly deliveries required; the City of Tampa's medical and first aid supplies ITB (estimated at $700,000) was due March 13, 2026 and includes a 5 percent Small Local Business Enterprise discount not to exceed $10,000. The Texas HHS Commission's RFI for direct-to-manufacturer prescriptions (posted April 3, 2026) functions as preliminary market intelligence gathering ahead of formal RFP issuance. MMCAP's generic pharmaceutical and OTC products RFP (due March 26, 2026, with awards effective July 1, 2026) emphasizes price competitiveness weighted at 75 percent and requires vendor relationships with three designated wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson) operating under chargeback systems with cGMP and DSCSA compliance required.